-
Australian state overturns Melbourne ban on World Cup watch party
-
Colombian ex-fisherman swaps trade for saving Caribbean coral
-
Lobito Corridor: Africa's mega-project facing delivery test
-
Africa's Lobito Corridor chief tells AFP business, not geopolitics, drives strategy
-
Trump to host Lula in test of fitful relationship
-
K-pop stars BTS draw 50,000-strong crowd in Mexico
-
Britons set to punish Starmer's Labour in local polls
-
Wars in Middle East, backyard loom over ASEAN summit
-
US court releases purported Epstein suicide note
-
Israeli court rejects flotilla activists' appeal challenging detention
-
Victim's lawyer alleges Boeing was 'negligent' in 2019 Ethiopian crash
-
Williamson named in New Zealand squad for Ireland, England Tests
-
PSG add muscle to magic as another Champions League final beckons
-
Tigers' pitcher Valdez suspended for hitting opponent
-
Trump says Iran deal 'very possible' but threatens strikes if talks fail
-
Musk's SpaceX strikes data center deal with Anthropic
-
Bayern lament lack of 'killer' instinct after PSG elimination
-
Virus-hit cruise ship heads for Spain as evacuees land in Europe
-
Holders PSG edge Bayern Munich to reach Champions League final
-
Russia warns diplomats in Kyiv to evacuate in case of strike
-
Hantavirus ship passenger: 'They didn't take it seriously enough'
-
First hantavirus infection could not have been during cruise: WHO expert
-
Kentucky Derby-winner Golden Tempo to skip Preakness Stakes
-
Trump says Iran deal 'very possible', but threatens strikes if not
-
Lula heads to Washington to meet Trump in fraught election year
-
No timeline for injury return for 'frustrated' Doncic
-
Virus-hit cruise ship evacuees land in Europe
-
Diallo says Manchester United squad happy if Carrick stays
-
'Motivated' McIlroy ready to tee it up for first time since second Masters win
-
Klaasen knock fires Hyderabad top of IPL
-
French aircraft carrier pre-positions for possible Hormuz mission
-
Villa's future is bright even if Europa dream ends: Emery
-
Departing Glasner wants no sadness as Palace eye European glory
-
Seixas targets victory in Tour warm-up race
-
'Oh, gosh': Inside the race to test for cruise ship hantavirus
-
Wave of arrests, abductions after attacks on Mali junta
-
Virus-hit cruise ship evacuees head to Spain, Netherlands
-
FIFA extends Prestianni ban worldwide
-
EU risks financial hit if Chinese suppliers forced out: trade group
-
G7 decries 'economic coercion' in swipe at China
-
Pioneering CNN founder Ted Turner dead at 87
-
CNN founder Ted Turner: 20th century media giant
-
Forest to make late decision on Gibbs-White fitness for Villa Europa semi
-
Malian singer Rokia Traore gets suspended jail in Belgian custody case
-
Disney shares jump after results top expectations
-
Cruise ship passenger with hantavirus being treated in Zurich
-
Ryanair's O'Leary urges pre-flight morning booze ban
-
Ghana artist's billboard campaign takes aim at fast fashion fallout
-
Biogas helps cut bills, deforestation in east DR Congo
-
Protests as Venice Biennale opens in turmoil over Russian presence
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
A.Mahlangu--AMWN